Royce & Associates’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,672
Closed -$23K 1089
2020
Q2
$23K Sell
1,672
-160
-9% -$2.22K ﹤0.01% 1112
2020
Q1
$19K Buy
1,832
+199
+12% +$2.73K ﹤0.01% 1093
2019
Q4
$25K Sell
1,633
-429
-21% -$6.31K ﹤0.01% 1091
2019
Q3
$28K Buy
2,062
+629
+44% +$7.67K ﹤0.01% 1101
2019
Q2
$19K Buy
1,433
+206
+17% +$2.45K ﹤0.01% 1119
2019
Q1
$18K Buy
1,227
+252
+26% +$3.66K ﹤0.01% 1128
2018
Q4
$13K Sell
975
-315
-24% -$3.77K ﹤0.01% 1134
2018
Q3
$14K Buy
+1,290
New +$13.7K ﹤0.01% 1169
2017
Q4
Sell
-1,384
Closed -$6K 1260
2017
Q3
$6K Buy
+1,384
New +$5.42K ﹤0.01% 1216

Other funds holding LFVN

Royce & Associates's LFVN Position: Q3 2020 in Review

Royce & Associates sold out of LifeVantage (LFVN) in Q3 2020, closing a stake of 1,672 shares — an estimated $23K sold.

Royce & Associates first reported a position in LFVN in Q3 2017 and held it in 9 quarters. The position peaked at $28K in Q3 2019. 89 funds tracked by Wall St. Rank hold LFVN as of Q3 2020.

  • Royce & Associates reported no remaining LifeVantage position as of Q3 2020 after selling out during the quarter.
  • Royce & Associates sold 1,672 LifeVantage shares in Q3 2020, an estimated $23K.
  • Royce & Associates first reported a position in LifeVantage in Q3 2017 and held it in 9 quarters.
  • Royce & Associates's LifeVantage position peaked at $28K in Q3 2019.
  • 89 funds tracked by Wall St. Rank held LifeVantage as of Q3 2020.

Based on Royce & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.